
- Viemed Healthcare (VMD) demonstrates strong technical momentum and is trading at a new 2-year high.
- Shares are up more than 30% over the past 52 weeks.
- VMD maintains a 100% “Buy” technical opinion from Barchart.
- I see VMD as an attractive investment opportunity, combining strong growth, profitability, and technical strength at a $355 million market cap.